Menglu Dong

491 total citations
22 papers, 306 citations indexed

About

Menglu Dong is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Menglu Dong has authored 22 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Menglu Dong's work include RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (7 papers) and MicroRNA in disease regulation (6 papers). Menglu Dong is often cited by papers focused on RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (7 papers) and MicroRNA in disease regulation (6 papers). Menglu Dong collaborates with scholars based in China and United States. Menglu Dong's co-authors include Tao Xu, Hanning Li, Xingrui Li, Wenfei Xia, Qi Zhang, Xingrui Li, Yi Xu, Chenao Zhan, Quan Liu and Rui Zhang and has published in prestigious journals such as The Astrophysical Journal, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Menglu Dong

22 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Menglu Dong China 12 214 138 74 70 23 22 306
Joanna L. Gillis Australia 8 286 1.3× 195 1.4× 48 0.6× 128 1.8× 22 1.0× 9 397
Adrienne R. Hanson Australia 9 241 1.1× 168 1.2× 106 1.4× 175 2.5× 24 1.0× 15 438
Sean Cory Canada 11 236 1.1× 95 0.7× 134 1.8× 86 1.2× 19 0.8× 15 409
Louie Semaan United States 8 169 0.8× 88 0.6× 106 1.4× 139 2.0× 25 1.1× 10 347
Kari‐Anne M. Frikstad Norway 8 183 0.9× 115 0.8× 41 0.6× 76 1.1× 8 0.3× 10 283
Liantao Guo China 7 92 0.4× 76 0.6× 121 1.6× 55 0.8× 17 0.7× 14 266
Danielle Choi United States 9 147 0.7× 87 0.6× 79 1.1× 141 2.0× 15 0.7× 11 294
Franziska Niehr Germany 8 175 0.8× 77 0.6× 136 1.8× 56 0.8× 8 0.3× 10 276
Ulrich Vogel Germany 8 234 1.1× 106 0.8× 91 1.2× 51 0.7× 10 0.4× 17 379
Wuzhong Jiang China 9 213 1.0× 104 0.8× 104 1.4× 63 0.9× 8 0.3× 17 337

Countries citing papers authored by Menglu Dong

Since Specialization
Citations

This map shows the geographic impact of Menglu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menglu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menglu Dong more than expected).

Fields of papers citing papers by Menglu Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Menglu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menglu Dong. The network helps show where Menglu Dong may publish in the future.

Co-authorship network of co-authors of Menglu Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Menglu Dong. A scholar is included among the top collaborators of Menglu Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Menglu Dong. Menglu Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ge, Yaying Du, Tao Xu, et al.. (2024). Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids. Cell Proliferation. 57(8). e13634–e13634. 4 indexed citations
2.
Dong, Menglu, et al.. (2024). Reoxygenation Mitigates Intermittent Hypoxia-Induced Systemic Inflammation and Gut Microbiota Dysbiosis in High-Fat Diet-Induced Obese Rats. Nature and Science of Sleep. Volume 16. 517–530. 1 indexed citations
3.
Yang, Xue, Yonglin Wu, Hanning Li, et al.. (2023). Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery. BMC Endocrine Disorders. 23(1). 113–113. 6 indexed citations
4.
Lv, Wenchang, Yichen Wang, Chongru Zhao, et al.. (2023). A novel immune score model predicting the prognosis and immunotherapy response of breast cancer. Scientific Reports. 13(1). 6403–6403. 3 indexed citations
5.
Dong, Menglu, Quan Liu, Yi Xu, & Qi Zhang. (2022). Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 842898–842898. 22 indexed citations
6.
Dong, Menglu, et al.. (2022). The emerging roles and mechanism of m6a in breast cancer progression. Frontiers in Genetics. 13. 983564–983564. 10 indexed citations
7.
Dong, Menglu, et al.. (2022). Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 785058–785058. 10 indexed citations
8.
Yang, Xue, Ge Wang, Hanning Li, et al.. (2022). Regulation of antitumor miR-205 targets oncogenes: Direct regulation of lymphoid specific helicase and its clinical significance. Life Sciences. 309. 120993–120993. 1 indexed citations
9.
Li, Hanning, Huimin Zhang, Xingrui Li, et al.. (2022). MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44. Endocrinology. 163(4). 14 indexed citations
10.
Li, Hanning, Xiang Zhou, Ge Wang, et al.. (2021). CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 107(4). 1110–1126. 27 indexed citations
11.
Wang, Zhi, Di Wu, Menglu Dong, Yu Xia, & Tao Xu. (2021). KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration. Translational Cancer Research. 10(1). 261–272. 6 indexed citations
12.
Wang, Ge, Hanning Li, Tao Xu, et al.. (2021). S100A1 is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis. Journal of Cancer. 12(19). 5760–5771. 16 indexed citations
13.
14.
Dong, Menglu, Tao Xu, Hanning Li, & Xingrui Li. (2021). LINC00052 promotes breast cancer cell progression and metastasis by sponging miR‑145‑5p to modulate TGFBR2 expression. Oncology Letters. 21(5). 368–368. 11 indexed citations
15.
Xu, Tao, Menglu Dong, Zhi Wang, Hanning Li, & Xingrui Li. (2020). <p>Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer</p>. Cancer Management and Research. Volume 12. 5773–5786. 17 indexed citations
16.
Xia, Wenfei, Yun Liu, Teng Cheng, et al.. (2020). Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1. Journal of Experimental & Clinical Cancer Research. 39(1). 18–18. 32 indexed citations
17.
Xu, Tao, Menglu Dong, Hanning Li, Rui Zhang, & Xingrui Li. (2020). Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer. Oncology Letters. 19(6). 4053–4065. 22 indexed citations
18.
Xu, Tao, Zhi Wang, Menglu Dong, et al.. (2020). Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer. Aging. 12(17). 17305–17327. 9 indexed citations
19.
Li, Hanning, Weihong Zheng, Yaying Du, et al.. (2020). ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: An integrated bioinformatics analysis. Oncology Letters. 19(3). 2163–2174. 14 indexed citations
20.
Xu, Tao, Rui Zhang, Menglu Dong, et al.. (2019). <p>Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway</p>. OncoTargets and Therapy. Volume 12. 10639–10650. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna L. Gillis Breakdown of academic impact, for papers by Adrienne R. Hanson Breakdown of academic impact, for papers by Sean Cory Breakdown of academic impact, for papers by Louie Semaan Breakdown of academic impact, for papers by Kari‐Anne M. Frikstad Breakdown of academic impact, for papers by Liantao Guo Breakdown of academic impact, for papers by Danielle Choi Breakdown of academic impact, for papers by Franziska Niehr Breakdown of academic impact, for papers by Ulrich Vogel Breakdown of academic impact, for papers by Wuzhong Jiang
Rankless by CCL
2026